治疗过敏性鼻炎的口服抗胰岛素的有效性和安全性:网络元分析
Rafael José Vieira1, Sara Gil-Mata1, André Ferreira2
1MEDCIDS - Department of Community Medicine, Information and Health Decision Sciences; Faculty of Medicine, University of Porto, Porto, Portugal; CINTESIS@RISE - Health Research Network, MEDCIDS, Faculty of Medicine, University of Porto, Porto, Portugal.
The journal of allergy and clinical immunology. In practice
|February 18, 2026
概括
口服H1-抗组胺剂 (OAH) 提供过敏性鼻炎 (AR) 的缓解. 虽然一些OAH显示出稍微更好的疗效,但大多数第二代选择具有相似的安全性概况和在疗效方面存在微小的差异.
科学领域:
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
- 基于证据的医学基于证据的医学.
背景情况:
- 口服H1-抗组胺剂 (OAH) 经常被用于过敏性鼻炎 (AR).
- 评估不同OAH的比较疗效和安全性对于临床决策至关重要.
研究的目的:
- 进行系统审查和网络元分析.
- 在AR患者中比较单个OAH的疗效和安全性.
主要方法:
- 搜索了多个数据库的随机对照试验 (RCT),比较OAH与安慰剂或个人OAH.
- 对症状得分,生活质量和不良事件进行了网络元分析.
- 使用GRADE-NMA对第二代OAH进行证据的评估确定性.
主要成果:
- 包括74个RCT (21个常年AR,53个季节性AR).
- 塞蒂里辛,埃巴斯丁,比拉斯丁和鲁帕达丁对鼻腔症状具有很高的疗效;其他结果各不相同.
- 第二代OAH中不良事件的发生率相似;严重事件很少发生.
- 证据的确定性通常很低或非常低.
结论:
- 一些OAH可能更有效,但第二代药物之间的差异通常是微不足道的.
- 在第二代OAH中没有发现安全性概况的显著差异.
- 由于证据的确定性较低,对治疗效果存在相当大的不确定性.
相关概念视频
Upper Respiratory Drugs: First and Second-Generation Antihistamines
1.4K
Antihistamines are a class of drugs widely used to alleviate the symptoms of allergies, such as sneezing, itching, and nasal congestion. They work by inhibiting the actions of histamine, which is released by immune cells in response to allergenic substances or tissue injuries.
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
1.4K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.9K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.9K
Upper Respiratory Drugs: Decongestants
995
Decongestants are a class of medications used primarily to alleviate nasal congestion, a common symptom resulting from allergies, colds, sinusitis, and other upper respiratory tract infections. These drugs work by activating α-adrenergic receptors, constricting small blood vessels in the nasal membranes. This action results in the opening of clogged nasal passages, thereby facilitating sinus drainage and relieving congestion.
Most decongestants are readily available over-the-counter in...
Most decongestants are readily available over-the-counter in...
995
Drugs Used in Upper Respiratory Disorders: Overview
719
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
719
Adrenergic Agonists: Mixed-Action Agents
1.6K
Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
1.6K
Antiasthma Drugs: Leukotriene Modifiers
1.9K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.9K


